12/29/2025
DON'T MISS OUT! Unmet Needs in Graves’ Disease: Evolving Treatment Patterns and Future Management Strategies
Thursday, January 29, 2026
08:00 PT, 11:00 ET, 17:00 CET
Graves’ disease is an autoimmune disorder and the most common cause of hyperthyroidism, affecting approximately 2% of women and 0.2% of men worldwide. Current standard-of-care treatments have remained largely unchanged for 75 years and aim to reduce or eliminate the production of thyroid hormones, rather than target the underlying autoimmune pathology that causes the disease.
In this webinar, two experts in Graves’ disease discuss emerging strategies to address unmet needs in the management of the condition.
Register now for this complimentary webinar sponsored by Immunovant INC: https://hubs.li/Q03YDZm40